Genmab har 12 lægemiddelkandidater, der kan blive den næste vinder

Intet revolutionerende nyt, men et godt indblik i Genmab som en biotekkoncern, som er meget mere end konglemarvsmidlet Darzalex.

You can skip to the end and leave a response. Pinging is currently not allowed.

Leave a Reply

You must be logged in to post a comment.

Powered by WordPress | Designed by: Premium Themes | Thanks to Free WordPress 4 Themes, Download Premium WordPress Themes and
%d bloggers like this: